Mass. Dx firm raises funds to further develop autism test

03/28/2013 | American City Business Journals

SynapDx has received an undisclosed investment from the Kraft Group, the third round of financing for the firm since December. The Massachusetts-based company will use the money to advance the development of its blood-based test for the early detection of autism spectrum disorder in children.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations